Figure 3: QLT0267 pharmacokinetic profile. QLT0267 treated animals (n=4 per time-point) were terminated by CO2 asphyxiation at 2, 4, 6 and 24 hours after treatmentand blood was collected by cardiac puncture. Subsequently, plasma was separated from blood cells and subject to LC-MS to determine concentrations of QLT0267 in plasma. The majority of QLT0267 was eliminated from the blood compartment within 6 hours (red arrow) where the AUC=37809 ng/ml*h.